{"id":8528,"date":"2026-02-26T16:01:07","date_gmt":"2026-02-26T16:01:07","guid":{"rendered":"https:\/\/www.vanguardlifesciences.co.uk\/?post_type=case-study&p=8528"},"modified":"2026-02-26T16:24:29","modified_gmt":"2026-02-26T16:24:29","slug":"cell-and-gene-therapy","status":"publish","type":"case-study","link":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/case-study\/cell-and-gene-therapy\/","title":{"rendered":"Die Schl\u00fcsseleinheit f\u00fcr Zell- und Gentherapie (CGT) in Gro\u00dfbritannien, Enbloc, f\u00fchrte den kompletten Innenausbau durch."},"content":{"rendered":"
\"\"<\/figure>\n

Diese neue Anlage bietet dem Kunden eine moderne, flexible und gut gestaltete Einrichtung mit Reinraumsuiten und Laboren, Umkleider\u00e4umen und B\u00fcroarbeitspl\u00e4tzen, die mit dem bestehenden Geb\u00e4ude am NHS BT-Standort in Bristol verbunden ist.<\/p>\n

Enbloc<\/a> Die gesamte Planung, der Bau und die Ausstattung wurden in Zusammenarbeit mit dem Kunden abgeschlossen, um im ersten Stock kontrollierte und klassifizierte Reinr\u00e4ume mit unterst\u00fctzenden Laboren und B\u00fcros im Erdgeschoss zu schaffen.<\/p>\n

Enbloc arbeitet weiterhin mit NHS BT im Rahmen eines laufenden Validierungs- und Wartungsvertrags f\u00fcr diesen Standort zusammen.<\/p>\n

\"\"<\/figure>\n
\"\"<\/figure>\n
\"\"<\/figure>\n
\"\"<\/figure>","protected":false},"excerpt":{"rendered":"

Enbloc wurde als Generalunternehmer f\u00fcr Planung und Bau ausgew\u00e4hlt, um die neue Erweiterungsanlage des Zentrums f\u00fcr klinische Biotechnologie am NHS BT in Filton zu errichten.<\/p>","protected":false},"author":18,"featured_media":8568,"template":"","format":"standard","case-study-category":[],"case-study-topic":[],"class_list":["post-8528","case-study","type-case-study","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nCell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/case-study\/cell-and-gene-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences\" \/>\n<meta property=\"og:description\" content=\"Enbloc were selected as the Design and Build turnkey Contractor to provide the new Clinical Biotechnology Centre Expansion Facility at the NHS BT in Filton\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/case-study\/cell-and-gene-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Vanguard Life Sciences\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-26T16:24:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"795\" \/>\n\t<meta property=\"og:image:height\" content=\"577\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/\",\"name\":\"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/1-4.png\",\"datePublished\":\"2026-02-26T16:01:07+00:00\",\"dateModified\":\"2026-02-26T16:24:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/1-4.png\",\"contentUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/1-4.png\",\"width\":795,\"height\":577},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/cell-and-gene-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\",\"name\":\"Vanguard Life Sciences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/case-study\/cell-and-gene-therapy\/","og_locale":"de_DE","og_type":"article","og_title":"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences","og_description":"Enbloc were selected as the Design and Build turnkey Contractor to provide the new Clinical Biotechnology Centre Expansion Facility at the NHS BT in Filton","og_url":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/case-study\/cell-and-gene-therapy\/","og_site_name":"Vanguard Life Sciences","article_modified_time":"2026-02-26T16:24:29+00:00","og_image":[{"width":795,"height":577,"url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2 Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/","url":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/","name":"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout - Vanguard Life Sciences","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#primaryimage"},"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png","datePublished":"2026-02-26T16:01:07+00:00","dateModified":"2026-02-26T16:24:29+00:00","breadcrumb":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#primaryimage","url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png","contentUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/1-4.png","width":795,"height":577},{"@type":"BreadcrumbList","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/cell-and-gene-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vanguardlifesciences.co.uk\/"},{"@type":"ListItem","position":2,"name":"Cell and Gene Therapy Key CGT unit in the UK, Enbloc carried out complete D&B fitout"}]},{"@type":"WebSite","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website","url":"https:\/\/www.vanguardlifesciences.co.uk\/","name":"Vanguard Life Sciences","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vanguardlifesciences.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"}]}},"_links":{"self":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/case-study\/8528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/case-study"}],"about":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/types\/case-study"}],"author":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/users\/18"}],"version-history":[{"count":0,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/case-study\/8528\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/media\/8568"}],"wp:attachment":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/media?parent=8528"}],"wp:term":[{"taxonomy":"case-study-category","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/case-study-category?post=8528"},{"taxonomy":"case-study-topic","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/case-study-topic?post=8528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}